Welcome to our dedicated page for KCAC SEC filings (Ticker: KCAC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on KCAC's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into KCAC's regulatory disclosures and financial reporting.
Kensington Capital Acquisition Corp. VI closed its SPAC IPO, selling 23,000,000 units at $10.00 each, with the underwriters’ over-allotment fully exercised, and placing $230,000,000 of proceeds into a trust account for future acquisitions.
The SPAC now has 24 months from the March 5, 2026 closing to complete an initial business combination, with public shareholders entitled to redeem their Class A shares for approximately $10.00 per share plus eligible interest. An audited balance sheet shows total assets of $232,353,660, including $230,000,000 of cash held in the trust.
Kensington Capital Acquisition Corp. VI completed its initial public offering of 23,000,000 units at $10.00 per unit, raising $230,000,000 in gross proceeds. Each unit includes one Class A ordinary share, one-quarter of one Class 1 redeemable warrant and three-quarters of one Class 2 redeemable warrant, each whole warrant exercisable at $11.50 per share.
The company also sold 14,600,000 Private Placement Warrants for $7,300,000 to its sponsor and underwriters. A total of $230,000,000, including $9,200,000 of deferred underwriting discount, was placed in a U.S. trust account to fund a future business combination within 24 months or redeem public shares.
The company appointed a full slate of independent directors, formed audit, compensation, and nominating committees, and adopted amended and restated constitutional documents as it begins searching for a target in automotive, defense, energy and artificial intelligence sectors.